CAS 361442-04-8 Purity > 99.0% (HPLC) API
Ruifu Chemical Supply Related Intermediates
CAS Nr .: 361442-04-8
CAS Nr .: 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
Tom ntej: 1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid Tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Synonyms | BMS-477118;Onglyza;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxy-1-Adamantyl)acetyl]-2-Azabicyclo[3.1.0] hexane-3-Carbonitrile;(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-Hydroxytricyclo [3.3.1.13,7]dec-1-yl)acetyl]-2-Azabicyclo[3.1.0] hexane -3-Carbonitrile |
CAS Nr | 361442-04-8 |
CAT Number | RF-PI 1991 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C18H25N3O2 |
Molecular Luj | 315.41 Nws |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb hmoov |
tsw | Yam ntxwv |
kev txheeb xyuas | A: IR B: HPLC Retention Time |
Purity / Analysis Method | > 99.0% (HPLC) |
Clarity ntawm Kev daws Dej | Pob tshab, tsis muaj xim, tsis muaj teeb meem ncua |
Sieve Analysis | 100% Pass 80 Mesh |
Melting Point | 202.0 ~ 212.0 ℃ |
Poob rau ziab | <0.50% |
Sulfated tshauv | <0.20% |
Kev sib hloov tshwj xeeb | +174.0° ~ + 186.0° |
Ib leeg Impurity | <0.50% |
Tag nrho cov impurities | <1.00% |
Hnyav Hlau | <10ppm |
Arsenic (As) | <2.0ppm |
Lead (Pb) | <1.0ppm |
Cadmium (Cd) | <1.0ppm |
Residual Solvents | <100ppm |
Residual Tshuaj tua kab | Tsis zoo |
Microbiology | |
Tag Nrho Phaj suav | <1000cfu/g |
Poov & Pwm | <100cfu/g |
E. Coli | Tsis zoo |
S. Aureus | Tsis zoo |
Salmonella | Tsis zoo |
Txee lub neej | 24 lub hlis txij hnub tsim khoom yog tias khaws cia kom raug |
Test Standard | Enterprise Standard |
Kev siv | API;Hom 2 Mob ntshav qab zib mellitus |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo
(BMS-477118) (CAS: 361442-04-8) yog lub zog, xaiv, thim rov qab, sib tw thiab qhov ncauj nquag dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) inhibitor.BMS-477118 muaj qhov peotential rau hom 2 mob ntshav qab zib mellitus tshawb fawb.BMS-477118Nws yog hom 2 mob ntshav qab zib hom 2 uas tuaj yeem tsim cov tshuaj insulin ntau dua tom qab noj mov.Nws tau mus txog los ntawm kev koom tes ntawm AstraZeneca thiab Bristol-Myers Squibb Company thiab belongs rau DPP-IV inhibitor.BMS-477118plays lub luag hauj lwm los ntawm inhibiting GLP-l degradation.GLP-I yog cov tshuaj hormones tsim nyob rau hauv txoj hnyuv tom qab noj mov.Nws tuaj yeem tswj hwm qhov tso tawm ntawm insulin thiab ntxiv dag zog rau kev siv cov piam thaj hauv cov ntaub so ntswg peripheral.Cov tshuaj ib leeg ntawm BMS-477118 tuaj yeem txhim kho kev tswj ntshav qabzib thiab cov tshuaj sib xyaw ua ke ntawm BMS-477118 nrog Metformin, Sulfonylurea thiab Thiazolidinediones tuaj yeem txhim kho cov nyhuv curative.Nws ua rau muaj kev pheej hmoo tsawg ntawm hypoglycemia thiab nws cov kev cuam tshuam tsis zoo zoo ib yam li cov placebo, uas qhia tau tias muaj kev zam zoo dua.Lub Xya Hli 31, 2009, BMS-477118 ntsiav tshuaj (Onglyza), cov tshuaj tshiab ntawm hom 2 mob ntshav qab zib, koom ua ke tshawb fawb thiab tsim AstraZeneca thiab Bristol-Myers Squibb tau pom zoo los ntawm US FDA.Nws tuaj yeem noj ib hnub ib zaug los kho mob ntshav qab zib hom 2 nrog rau kev tswj kev noj zaub mov thiab kev tawm dag zog.